MetaCap

Artivion (AORT) vs Alpha Tau Medical (DRTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alpha Tau Medical (DRTS) has outperformed Artivion (AORT) over the past year, gaining 207.7% versus a loss of 59.8%. Over five years, DRTS leads with a +18.5% price change compared with -0.8% for AORT. Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $886.0 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AORT-59.76%DRTS+207.72%
+324%+123%-78%
Nov 21, 20251 yearNov 20, 2026
AORT-4.17%DRTS+18.62%
+157%+34%-90%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AORT versus DRTS key metrics
MetricAORTDRTS
Share price$18.16$11.76
Market cap$886.02M$1.09B
1-day change-2.00%+3.93%
YTD return-60.18%+137.47%
1-year return-59.76%+207.72%
5-year return-0.82%+18.50%
Forward P/E34.92—
EPS (TTM)$-0.36$-1.04
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$441.33M—
Revenue growth (YoY)+13.59%—
Net income (latest FY)$9.77M$-42.63M
Gross margin64.40%—
Operating margin7.65%—
Net margin2.21%—
52-week high$48.25$15.79
52-week low$18.12$3.65
Distance from 52-week high-62.36%-25.55%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+111.84%+75.24%
Average volume671.97K591.88K
Shares outstanding48.79M92.48M
Employees1,800121
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DRTS has outperformed AORT by 267.5 percentage points over the past year.

About Artivion

AORT stock →

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Health Care · Medical/Dental Instruments · 1,800 employees

About Alpha Tau Medical

DRTS stock →

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

Health Care · Medical/Dental Instruments · 121 employees

AORT vs DRTS FAQ

Which is bigger, Artivion or Alpha Tau Medical?

Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $886.02M for Artivion (AORT).

Which stock has performed better over the past year, AORT or DRTS?

DRTS returned +207.72% over the past 12 months, compared with -59.76% for AORT (price return, excluding dividends). Past performance does not predict future results.

Are Artivion and Alpha Tau Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons